Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Bacchu
S
S
Department of Haematology, University Hospitals of Wales, Cardiff, UK. srinivas.bacchu@gmail.com
Fegan
C
C
Neal
J
J
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009894:Opportunistic Infections / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D016781:Toxoplasmosis, Cerebral / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*